Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 336

1.

Usefulness of Endoscopic Ultrasound Elastography Combined With the Strain Ratio in the Estimation of Treatment Effect in Autoimmune Pancreatitis.

Ishikawa T, Kawashima H, Ohno E, Tanaka H, Maeda K, Sawada T, Yamamura T, Furukawa K, Nakamura M, Miyahara R, Ishigami M, Fujishiro M.

Pancreas. 2020 Feb;49(2):e21-e22. doi: 10.1097/MPA.0000000000001481. No abstract available.

PMID:
32049954
2.

Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis.

Taylor RS, Taylor RJ, Bayliss S, Hagstrom H, Nasr P, Schattenberg JM, Ishigami M, Toyoda H, Wai-Sun Wong V, Peleg N, Shlomai A, Sebastiani G, Seko Y, Bhala N, Younossi ZM, Anstee QM, McPherson S, Newsome PN; Collaborators.

Gastroenterology. 2020 Feb 3. pii: S0016-5085(20)30137-2. doi: 10.1053/j.gastro.2020.01.043. [Epub ahead of print]

3.

Relationship Between Adverse Events and Microbiomes in Advanced Hepatocellular Carcinoma Patients Treated With Sorafenib.

Yamamoto K, Kuzuya T, Honda T, Ito T, Ishizu Y, Nakamura M, Miyahara R, Kawashima H, Ishigami M, Fujishiro M.

Anticancer Res. 2020 Feb;40(2):665-676. doi: 10.21873/anticanres.13996.

PMID:
32014907
4.

Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects.

Kawakubo M, Tanaka M, Ochi K, Watanabe A, Saka-Tanaka M, Kanamori Y, Yoshioka N, Yamashita S, Goto M, Itoh M, Shirakawa I, Kanai S, Suzuki H, Sawada M, Ito A, Ishigami M, Fujishiro M, Arima H, Ogawa Y, Suganami T.

Sci Rep. 2020 Jan 22;10(1):983. doi: 10.1038/s41598-020-57935-6.

5.

Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis.

Yoshioka N, Ishigami M, Watanabe Y, Sumi H, Doisaki M, Yamaguchi T, Ito T, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Haruta JI, Fujishiro M.

Sci Rep. 2020 Jan 16;10(1):481. doi: 10.1038/s41598-019-57369-9.

6.

Enabling remote quantum emission in 2D semiconductors via porous metallic networks.

Fonseca JJ, Yeats AL, Blue B, Zalalutdinov MK, Brintlinger T, Simpkins BS, Ratchford DC, Culbertson JC, Grim JQ, Carter SG, Ishigami M, Stroud RM, Cress CD, Robinson JT.

Nat Commun. 2020 Jan 7;11(1):5. doi: 10.1038/s41467-019-13857-0.

7.

Morphological, cytological and genetic analyzes of the 'sango' mutant with the defects in basidiocarp development in edible mushroom Pleurotus pulmonarius.

Okuda Y, Ito M, Shimada Y, Ishigami M, Matsumoto T.

FEMS Microbiol Lett. 2019 Sep 1;366(18). pii: fnz227. doi: 10.1093/femsle/fnz227.

PMID:
31730201
8.

Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma.

Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Ishikawa T, Fujishiro M.

Hepatol Res. 2019 Nov 12. doi: 10.1111/hepr.13452. [Epub ahead of print]

PMID:
31721363
9.

Complete response of advanced hepatocellular carcinoma achieved by sorafenib dose re-escalation after failure of long-term low-dose-sorafenib treatment combined with transcatheter arterial chemoembolization: a case report.

Muto H, Kuzuya T, Ito T, Ishizu Y, Honda T, Ishikawa T, Ishigami M, Fujishiro M.

Clin J Gastroenterol. 2019 Nov 11. doi: 10.1007/s12328-019-01066-7. [Epub ahead of print]

PMID:
31709503
10.

Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver disease.

Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Toyoda H, Kumada T, Fujishiro M.

Eur J Gastroenterol Hepatol. 2019 Oct 30. doi: 10.1097/MEG.0000000000001587. [Epub ahead of print]

PMID:
31688305
11.

Rapid increase of platelet counts during antiviral therapy in patients with hepatitis C virus infection.

Ishizu Y, Ishigami M, Hayashi K, Honda T, Kuzuya T, Ito T, Fujishiro M.

Hepatol Res. 2020 Jan;50(1):47-56. doi: 10.1111/hepr.13426. Epub 2019 Oct 25.

PMID:
31496023
12.

Serum Nutritional Markers as Prognostic Factors for Hepatic and Extrahepatic Carcinogenesis in Japanese Patients with Nonalcoholic Fatty Liver Disease.

Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Toyoda H, Kumada T, Fujishiro M.

Nutr Cancer. 2019 Aug 21:1-8. doi: 10.1080/01635581.2019.1653474. [Epub ahead of print]

PMID:
31433263
13.

Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity.

Yoshioka N, Kuzuya T, Ito T, Ishizu Y, Honda T, Ishikawa T, Ishigami M, Fujishiro M.

Intern Med. 2019 Oct 1;58(19):2803-2808. doi: 10.2169/internalmedicine.2812-19. Epub 2019 Jun 27.

14.

Increased hardness of the underlying pancreas correlates with the presence of intraductal papillary-mucinous neoplasm in a limited number of cases.

Koya T, Kawashima H, Ohno E, Ishikawa T, Ishigami M, Hashimoto S, Goto H, Hirooka Y.

J Med Ultrason (2001). 2019 Oct;46(4):441-447. doi: 10.1007/s10396-019-00956-0. Epub 2019 Jun 19.

PMID:
31218473
15.

The Prevalence of Mixed Hepatitis C Virus Genotype Infection and Its Effect on the Response to Direct-Acting Antivirals Therapy.

Hayashi K, Tachi K, Shimizu Y, Nagano K, Ishizu Y, Kuzuya T, Honda T, Ishigami M, Hirooka Y, Hattori M, Goto H.

Intervirology. 2019;62(1):23-29. doi: 10.1159/000499691. Epub 2019 Jun 17.

PMID:
31207601
16.

Sarcopenia impairs health-related quality of life in cirrhotic patients.

Ando Y, Ishigami M, Ito T, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Fujishiro M.

Eur J Gastroenterol Hepatol. 2019 Dec;31(12):1550-1556. doi: 10.1097/MEG.0000000000001472.

PMID:
31206408
17.

Spleen stiffness by 2-D shear wave elastography is the most accurate predictor of high-risk esophagogastric varices in children with biliary atresia.

Yokoyama S, Ishigami M, Honda T, Kuzuya T, Ishizu Y, Ito T, Hirooka Y, Tanaka Y, Tainaka T, Shirota C, Chiba K, Uchida H, Fujishiro M.

Hepatol Res. 2019 Oct;49(10):1162-1168. doi: 10.1111/hepr.13381. Epub 2019 Jul 2.

PMID:
31132304
18.

The Propagation Display Method Improves the Reproducibility of Pancreatic Shear Wave Elastography.

Hashizume K, Hirooka Y, Kawashima H, Ohno E, Ishikawa T, Kawai M, Suhara H, Takeyama T, Koya T, Tanaka H, Sakai D, Yamamura T, Furukawa K, Funasaka K, Nakamura M, Miyahara R, Watanabe O, Ishigami M, Kuwahara T, Hashimoto S, Goto H.

Ultrasound Med Biol. 2019 Aug;45(8):2242-2247. doi: 10.1016/j.ultrasmedbio.2019.04.003. Epub 2019 May 16.

PMID:
31103347
19.

Clinical characteristics and outcomes of candidates for second-line therapy, including regorafenib and ramucirumab, for advanced hepatocellular carcinoma after sorafenib treatment.

Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Ishikawa T, Hirooka Y, Fujishiro M.

Hepatol Res. 2019 Sep;49(9):1054-1065. doi: 10.1111/hepr.13358. Epub 2019 May 29.

PMID:
31033165
20.

Clinical Impact of EUS-Guided Fine Needle Biopsy Using a Novel Franseen Needle for Histological Assessment of Pancreatic Diseases.

Ishikawa T, Kawashima H, Ohno E, Tanaka H, Sakai D, Iida T, Nishio R, Yamamura T, Furukawa K, Nakamura M, Miyahara R, Hashimoto S, Ishigami M, Hirooka Y.

Can J Gastroenterol Hepatol. 2019 Feb 3;2019:8581743. doi: 10.1155/2019/8581743. eCollection 2019.

21.

Antifibrotic Effects of 1,25(OH)2D3 on Nonalcoholic Steatohepatitis in Female Mice.

Ma L, Ishigami M, Honda T, Yokoyama S, Yamamoto K, Ishizu Y, Kuzuya T, Hayashi K, Hirooka Y, Goto H.

Dig Dis Sci. 2019 Sep;64(9):2581-2590. doi: 10.1007/s10620-019-05560-3. Epub 2019 Mar 2.

PMID:
30825110
22.

Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12 weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience.

Ueda Y, Kobayashi T, Ikegami T, Miuma S, Mizuno S, Akamatsu N, Takaki A, Ishigami M, Takatsuki M, Sugawara Y, Maehara Y, Uemoto S, Seno H.

J Gastroenterol. 2019 Jul;54(7):660-666. doi: 10.1007/s00535-019-01561-1. Epub 2019 Feb 26.

PMID:
30806783
23.

Influence of proton pump inhibitors on microbiota in chronic liver disease patients.

Yamamoto K, Ishigami M, Honda T, Takeyama T, Ito T, Ishizu Y, Kuzuya T, Hayashi K, Goto H, Hirooka Y.

Hepatol Int. 2019 Mar;13(2):234-244. doi: 10.1007/s12072-019-09932-9. Epub 2019 Feb 8.

PMID:
30737678
24.

Comparison of 8- and 10-mm diameter fully covered self-expandable metal stents: A multicenter prospective study in patients with distal malignant biliary obstruction.

Kawashima H, Hashimoto S, Ohno E, Ishikawa T, Morishima T, Matsubara H, Sugimoto H, Nonogaki K, Kanamori A, Hara K, Kuwahara T, Nakamura M, Miyahara R, Ishigami M, Ando M, Hirooka Y; Nagoya Biliary Stent Study (NABIS)-01 Group.

Dig Endosc. 2019 Jul;31(4):439-447. doi: 10.1111/den.13366. Epub 2019 Mar 29.

PMID:
30714216
25.

Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.

Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Nishimura D, Toyoda H, Kumada T, Goto H, Hirooka Y.

J Gastroenterol Hepatol. 2019 Jan;34(1):207-214. doi: 10.1111/jgh.14448. Epub 2018 Sep 18.

PMID:
30144360
26.

Successful treatment of esophageal bleeding due to rupture of major aortopulmonary collateral arteries by transcatheter arterial embolization.

Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Matsushima M, Kato T, Hirooka Y.

Clin J Gastroenterol. 2019 Feb;12(1):20-24. doi: 10.1007/s12328-018-0895-8. Epub 2018 Aug 21.

PMID:
30132302
27.

Effectiveness of a modified 6-Fr endoscopic nasobiliary drainage catheter for patients with preoperative perihilar cholangiocarcinoma.

Kawashima H, Hirooka Y, Ohno E, Ishikawa T, Miyahara R, Watanabe O, Hayashi K, Ishigami M, Hashimoto S, Ebata T, Nagino M, Goto H.

Endosc Int Open. 2018 Aug;6(8):E1020-E1030. doi: 10.1055/a-0614-2202. Epub 2018 Aug 10.

28.

Objective evaluation of blood flow in the small-intestinal villous: quantification of findings from dynamic endoscopy with concomitant narrow-band imaging.

Takeyama T, Hirooka Y, Kawashima H, Ohno E, Ishikawa T, Yamamura T, Furukawa K, Funasaka K, Nakamura M, Miyahara R, Ishigami M, Goto H.

Endosc Int Open. 2018 Aug;6(8):E941-E949. doi: 10.1055/a-0619-4965. Epub 2018 Aug 1.

29.

Human iPS cell-derived cardiac tissue sheets for functional restoration of infarcted porcine hearts.

Ishigami M, Masumoto H, Ikuno T, Aoki T, Kawatou M, Minakata K, Ikeda T, Sakata R, Yamashita JK, Minatoya K.

PLoS One. 2018 Aug 2;13(8):e0201650. doi: 10.1371/journal.pone.0201650. eCollection 2018.

30.

Complete response by vitamin K2 analog monotherapy in sorafenib-failure advanced hepatocellular carcinoma: A case report.

Kuzuya T, Ishigami M, Ishizu Y, Honda T, Hayashi K, Ishikawa T, Hirooka Y, Goto H.

Hepatol Res. 2019 Mar;49(3):360-364. doi: 10.1111/hepr.13237. Epub 2018 Aug 29.

PMID:
30051950
31.

Transabdominal ultrasound elastography of the esophagogastric junction predicts reflux esophagitis.

Suhara H, Hirooka Y, Kawashima H, Ohno E, Ishikawa T, Nakamura M, Miyahara R, Ishigami M, Hashimoto S, Goto H.

J Med Ultrason (2001). 2019 Jan;46(1):99-104. doi: 10.1007/s10396-018-0890-1. Epub 2018 Jul 24.

PMID:
30043241
32.

Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy.

Hayashi K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hirooka Y, Toyoda H, Kumada T, Hattori M, Katano Y, Goto H.

J Viral Hepat. 2018 Dec;25(12):1446-1451. doi: 10.1111/jvh.12967. Epub 2018 Jul 30.

PMID:
29993164
33.

Utility of contrast-enhanced ultrasonography with perflubutane in evaluating indications for diagnostic percutaneous tumor biopsy in a case of hepatic sclerosed hemangioma.

Ando Y, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hirooka Y.

Clin J Gastroenterol. 2018 Dec;11(6):514-520. doi: 10.1007/s12328-018-0880-2. Epub 2018 Jun 21.

PMID:
29931440
34.

Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease.

Tachi Y, Kozuka A, Hirai T, Kojima Y, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H.

Nutrition. 2018 Oct;54:83-88. doi: 10.1016/j.nut.2018.03.011. Epub 2018 Mar 21.

PMID:
29753174
35.

Substitutions in interferon sensitivity-determining region and hepatocarcinogenesis after hepatitis C virus eradication.

Yasuda S, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Toyoda H, Kumada T, Hirooka Y, Goto H.

J Gastroenterol Hepatol. 2018 Nov;33(11):1904-1911. doi: 10.1111/jgh.14280. Epub 2018 Jun 3.

PMID:
29744922
36.

Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response.

Tachi Y, Hirai T, Kojima Y, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H, Katano Y.

Eur J Gastroenterol Hepatol. 2018 Sep;30(9):1066-1072. doi: 10.1097/MEG.0000000000001159.

PMID:
29727381
37.

Prognostic Factors Associated with Postprogression Survival in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Not Eligible for Second-Line Regorafenib Treatment.

Kuzuya T, Ishigami M, Ishizu Y, Honda T, Hayashi K, Ishikawa T, Nakano I, Hirooka Y, Goto H.

Oncology. 2018;95(2):91-99. doi: 10.1159/000488453. Epub 2018 May 3.

PMID:
29723866
38.

Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C Virus.

Imai H, Kamei H, Onishi Y, Ishizu Y, Ishigami M, Goto H, Ogura Y.

Transplant Proc. 2018 Jun;50(5):1431-1436. doi: 10.1016/j.transproceed.2018.03.005. Epub 2018 Apr 25.

PMID:
29705278
39.

Functional Correlation Between the Pancreas and the Small Intestine in Humans: The First Evaluation Using a Newly Developed Enteroscopy.

Hayashi D, Hirooka Y, Kawashima H, Ohno E, Ishikawa T, Kuwahara T, Kawai M, Yamamura T, Furukawa K, Funasaka K, Nakamura M, Miyahara R, Watanabe O, Ishigami M, Hashimoto S, Goto H.

Pancreas. 2018 May/Jun;47(5):601-608. doi: 10.1097/MPA.0000000000001039.

PMID:
29683968
40.

Temporary sequestration of cholesterol and phosphatidylcholine within extracellular domains of ABCA1 during nascent HDL generation.

Ishigami M, Ogasawara F, Nagao K, Hashimoto H, Kimura Y, Kioka N, Ueda K.

Sci Rep. 2018 Apr 18;8(1):6170. doi: 10.1038/s41598-018-24428-6.

41.

Pseudomembranous Invasive Tracheobronchial Aspergillosis with Fulminant Hepatitis and Hemophagocytic Syndrome.

Majima S, Okachi S, Asano M, Wakahara K, Hashimoto N, Sato M, Ishigami M, Hasegawa Y.

Intern Med. 2018 Aug 15;57(16):2371-2375. doi: 10.2169/internalmedicine.9673-17. Epub 2018 Mar 30.

42.

Highly sensitive MoS2 photodetectors with graphene contacts.

Han P, St Marie L, Wang QX, Quirk N, El Fatimy A, Ishigami M, Barbara P.

Nanotechnology. 2018 May 18;29(20):20LT01. doi: 10.1088/1361-6528/aab4bb. Epub 2018 Mar 7.

PMID:
29512512
43.

Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver disease.

Tachi Y, Kozuka A, Hirai T, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H.

J Gastroenterol Hepatol. 2018 Feb 27. doi: 10.1111/jgh.14133. [Epub ahead of print]

PMID:
29486094
44.

Multiphase evaluation of contrast-enhanced endoscopic ultrasonography in the diagnosis of pancreatic solid lesions.

Ishikawa T, Hirooka Y, Kawashima H, Ohno E, Hashizume K, Funasaka K, Nakamura M, Miyahara R, Watanabe O, Ishigami M, Goto H.

Pancreatology. 2018 Apr;18(3):291-297. doi: 10.1016/j.pan.2018.02.002. Epub 2018 Feb 9.

PMID:
29449151
45.

Increase in breath hydrogen concentration was correlated with the main pancreatic duct stenosis.

Sakai D, Hirooka Y, Kawashima H, Ohno E, Ishikawa T, Suhara H, Takeyama T, Koya T, Tanaka H, Iida T, Nishio R, Suzuki H, Uetsuki K, Matsushita M, Yamamura T, Furukawa K, Funasaka K, Nakamura M, Miyahara R, Watanabe O, Ishigami M, Tsuruta A, Shin W, Goto H.

J Breath Res. 2018 Mar 12;12(3):036004. doi: 10.1088/1752-7163/aaaf77.

PMID:
29445052
46.

Risk factors for radiotherapy incidents: a single institutional experience.

Ishiyama H, Shuto N, Terazaki T, Noda S, Ishigami M, Yogo K, Hayakawa K.

Med Dosim. 2019 Spring;44(1):26-29. doi: 10.1016/j.meddos.2017.12.006. Epub 2018 Feb 1.

PMID:
29395460
47.

Endoscopic ultrasound in diagnosis of solid pancreatic lesions: Elastography or contrast-enhanced harmonic alone versus the combination.

Chantarojanasiri T, Hirooka Y, Kawashima H, Ohno E, Kuwahara T, Yamamura T, Funasaka K, Nakamura M, Miyahara R, Ishigami M, Watanabe O, Hashimoto S, Hirakawa A, Ratanachu-Ek T, Goto H.

Endosc Int Open. 2017 Nov;5(11):E1136-E1143. doi: 10.1055/s-0043-118829. Epub 2017 Nov 8.

48.

Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A-Y93.

Ishigami M, Hayashi K, Honda T, Kuzuya T, Ishizu Y, Ishikawa T, Nakano I, Urano F, Kumada T, Yoshioka K, Hirooka Y, Goto H.

J Med Virol. 2018 Apr;90(4):736-744. doi: 10.1002/jmv.24978. Epub 2017 Dec 28.

PMID:
29111616
49.

Observation of Effective Pseudospin Scattering in ZrSiS.

Lodge MS, Chang G, Huang CY, Singh B, Hellerstedt J, Edmonds MT, Kaczorowski D, Hosen MM, Neupane M, Lin H, Fuhrer MS, Weber B, Ishigami M.

Nano Lett. 2017 Dec 13;17(12):7213-7217. doi: 10.1021/acs.nanolett.7b02307. Epub 2017 Nov 20.

PMID:
29110492
50.

Liver stiffness measurement predicts hepatocellular carcinoma development in patients treated with direct-acting antivirals.

Tachi Y, Hirai T, Kojima Y, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M, Goto H.

JGH Open. 2017 Sep 18;1(1):44-49. doi: 10.1002/jgh3.12007. eCollection 2017 Sep.

Supplemental Content

Loading ...
Support Center